Crossmark

The advantages and challenges of disability-free survival as outcome measure in clinical studies

Crossref DOI link: https://doi.org/10.1038/s43587-025-00853-x

Published Online: 2025-04-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Neumann, Johannes T. https://orcid.org/0000-0002-9478-2757
McNeil, John J. https://orcid.org/0000-0002-1049-5129
License Information

Text and Data Mining valid from 2025-04-01

Version of Record valid from 2025-04-01
More Information

Article History

First Online: 1 April 2025

Competing interests

: J.T.N. reports honoraria from Abbott, PHC, Roche and Siemens outside the submitted work.